Herold S, Schmidt C, Visco C, Tilch MK, et al. The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell ly BMC Cancer 2025;25:1370.
PMID: 40855285